ACM
ABEO icon

Aster Capital Management’s Abeona Therapeutics ABEO Stock Holding History

Aster Capital Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-21,601
Closed -$120K – 1207
2024
Q4 		$120K Hold
21,601
– – 0.05% 351
2024
Q3 		$137K Buy
+21,601
New +$113K 0.03% 340

Other funds holding ABEO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Aster Capital Management's ABEO Position: Q1 2025 in Review

Aster Capital Management sold out of Abeona Therapeutics (ABEO) in Q1 2025, closing a stake of 21,601 shares — an estimated $120K sold.

Aster Capital Management first reported a position in ABEO in Q3 2024 and held it in 2 quarters. The position peaked at $137K in Q3 2024. 71 funds tracked by Wall St. Rank hold ABEO as of Q1 2025.

  • Aster Capital Management reported no remaining Abeona Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Aster Capital Management sold 21,601 Abeona Therapeutics shares in Q1 2025, an estimated $120K.
  • Aster Capital Management first reported a position in Abeona Therapeutics in Q3 2024 and held it in 2 quarters.
  • Aster Capital Management's Abeona Therapeutics position peaked at $137K in Q3 2024.
  • 71 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2025.

Based on Aster Capital Management's 13F filing for Q1 2025, filed 15 May 2025.